Intensity Therapeutics, Inc. (INTS) Q4 2023 Earnings Report

250 Followers

INTS Q4 2023 EPS Results

Actual EPS-$5.75

Consensus EPS-$4.50

Beat/MissMissed by -$1.25

One Year Ago EPS-$0.12

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ4 2023

Date03/14/2024

TimeAfter Close

Conference CallThursday, March 14, 2024

INTS Upcoming Earnings

Intensity Therapeutics, Inc.'s next earnings date is estimated for November 17, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-0.99 / -	-1.5	―
Aug 11, 2026	2026 (Q2)	-0.87 / -1.11	-3.25	65.85% (+2.14)
May 07, 2026	2026 (Q1)	-1.08 / -0.96	-5.5	82.55% (+4.54)
Mar 27, 2026	2025 (Q4)	-1.24 / 1.69	-5.5	130.73% (+7.19)
Nov 06, 2025	2025 (Q3)	-1.58 / -1.50	-6.25	76.00% (+4.75)
Aug 07, 2025	2025 (Q2)	-4.25 / -3.25	-9	63.89% (+5.75)
May 13, 2025	2025 (Q1)	-5.00 / -5.50	-8.5	35.29% (+3.00)
Mar 13, 2025	2024 (Q4)	-5.60 / -5.50	-5.75	4.35% (+0.25)
Nov 13, 2024	2024 (Q3)	-7.63 / -6.25	-4.25	-47.06% (-2.00)
Aug 08, 2024	2024 (Q2)	-8.00 / -9.00	-35.75	74.83% (+26.75)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed